Altimmune, Inc.ALTNASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank93
5Y CAGR+194.0%
Studio
Year-over-Year Change

Price-to-sales ratio

5Y CAGR
+194.0%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
219.6x
Strong expansion
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
20257757.46-69.7%
202425596.73+1720.3%
20231406.17+112.4%
2022-11352.04-13338.5%
202185.75+142.7%
202035.33+726.3%
20194.28+665.2%
20180.56-99.9%
2017613.98+10364.5%
20165.87-